Published in Gene Therapy Weekly, March 15th, 2001
Noel Bouck, professor of microbiology and immunology at the Northwestern University Medical School, Chicago, Illinois, who discovered the use of this protein in inhibiting angiogenesis, said PEDF may have important therapeutic implications in diabetic retinopathy and macular...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.